Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
0.980
-0.002 (-0.22%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Sunshine Biopharma Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 9.12 | 9.69 | 16.29 | 21.83 | 2.05 | Upgrade
|
| Short-Term Investments | - | - | - | - | 0.01 | Upgrade
|
| Cash & Short-Term Investments | 9.12 | 9.69 | 16.29 | 21.83 | 2.05 | Upgrade
|
| Cash Growth | -5.81% | -40.55% | -25.36% | 963.27% | 105.79% | Upgrade
|
| Accounts Receivable | 3.46 | 3.87 | 2.55 | 1.91 | 0.01 | Upgrade
|
| Receivables | 3.46 | 3.87 | 2.55 | 1.91 | 0.01 | Upgrade
|
| Inventory | 13.47 | 11.28 | 5.73 | 3.29 | 0.11 | Upgrade
|
| Prepaid Expenses | 0.8 | 1.13 | 0.31 | 0.28 | 0.03 | Upgrade
|
| Total Current Assets | 26.85 | 25.97 | 24.89 | 27.31 | 2.2 | Upgrade
|
| Property, Plant & Equipment | 1.34 | 1.48 | 1.01 | 1.15 | 0.01 | Upgrade
|
| Other Intangible Assets | 1.89 | 3.02 | 1.44 | 0.78 | - | Upgrade
|
| Long-Term Deferred Tax Assets | - | 0.09 | - | - | - | Upgrade
|
| Total Assets | 30.08 | 30.56 | 27.35 | 29.24 | 2.2 | Upgrade
|
| Accounts Payable | 5.66 | 5.54 | 2.59 | 2.8 | 0.04 | Upgrade
|
| Accrued Expenses | - | - | - | - | 0.05 | Upgrade
|
| Current Portion of Leases | 0.22 | 0.21 | 0.12 | 0.12 | - | Upgrade
|
| Current Income Taxes Payable | 0.27 | 0.27 | 0.3 | 0.37 | - | Upgrade
|
| Other Current Liabilities | 0.3 | 0.3 | 2.55 | 3.63 | - | Upgrade
|
| Total Current Liabilities | 6.44 | 6.31 | 5.55 | 6.93 | 0.09 | Upgrade
|
| Long-Term Debt | - | - | - | - | 1.9 | Upgrade
|
| Long-Term Leases | 0.6 | 0.74 | 0.54 | 0.64 | - | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | 0.05 | 0.04 | - | Upgrade
|
| Total Liabilities | 7.04 | 7.06 | 6.14 | 7.62 | 1.99 | Upgrade
|
| Common Stock | 0 | 0 | 0 | 0.02 | 0 | Upgrade
|
| Additional Paid-In Capital | 98.1 | 93.35 | 84.42 | 80.84 | 32.79 | Upgrade
|
| Retained Earnings | -75.02 | -69.04 | -63.91 | -59.4 | -32.66 | Upgrade
|
| Comprehensive Income & Other | -0.07 | -0.83 | 0.7 | 0.16 | -0.02 | Upgrade
|
| Total Common Equity | 23.03 | 23.49 | 21.21 | 21.63 | 0.11 | Upgrade
|
| Shareholders' Equity | 23.04 | 23.5 | 21.21 | 21.63 | 0.21 | Upgrade
|
| Total Liabilities & Equity | 30.08 | 30.56 | 27.35 | 29.24 | 2.2 | Upgrade
|
| Total Debt | 0.81 | 0.95 | 0.66 | 0.77 | 1.9 | Upgrade
|
| Net Cash (Debt) | 8.31 | 8.73 | 15.63 | 21.06 | 0.15 | Upgrade
|
| Net Cash Growth | -4.84% | -44.14% | -25.77% | 13687.37% | - | Upgrade
|
| Net Cash Per Share | 2.00 | 12.45 | 1219.08 | - | - | Upgrade
|
| Filing Date Shares Outstanding | 4.91 | 2.71 | 0.05 | 0.01 | - | Upgrade
|
| Total Common Shares Outstanding | 4.91 | 2.58 | 0.01 | 0.01 | - | Upgrade
|
| Working Capital | 20.41 | 19.65 | 19.34 | 20.38 | 2.1 | Upgrade
|
| Book Value Per Share | 4.69 | 9.10 | 1513.44 | 1915.04 | - | Upgrade
|
| Tangible Book Value | 21.14 | 20.47 | 19.76 | 20.85 | 0.11 | Upgrade
|
| Tangible Book Value Per Share | 4.31 | 7.93 | 1410.37 | 1846.25 | - | Upgrade
|
| Machinery | - | 0.79 | 0.54 | 0.48 | - | Upgrade
|
| Leasehold Improvements | - | 0.09 | 0.02 | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.